ArticleFrontiers in neuroscience2025
Clinical characteristics and risk factors of depression in prodromal Parkinson's disease.
Article in Frontiers in neuroscience, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Depression is a highly prevalent non-motor symptom in Parkinson's disease (PD) that can manifest several years prior to the clinical diagnosis of PD. The study was aimed to investigate the clinical characteristics and related risk factors of depression in prodromal PD (pPD) subjects. Methods: A total of 47 pPD participants from community population of East China and 39 healthy controls (HCs) were enrolled in the study. The pPD people were divided into two groups (pPD with depression and pPD without depression) according to the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-V) criteria. The severity of depression was assessed via the 24-item Hamilton Depression Rating Scale (HAMD-24), and the clinical features of depression were assessed by calculating seven factors of the HAMD-24. Comparisons between the two pPD subgroups were conducted to evaluate the clinical characteristics of depression in the prodromal phase of PD. Risk factors for depression in prodromal PD were analyzed by multivariate Logistic regression analysis. Results: The prevalence of depression in prodromal PD was 25.53%. pPD group with depression (dpPD) had significantly less years of education and higher HAMD overall scores, Hamilton Anxiety Rating Scale (HAMA) scores, PD non-motor questionnaire scores compared with pPD without depression (ndpPD). The dpPD group obtained significantly higher scores than the ndpPD group across several domains, including anxiety/somatization, cognitive impairment, day/night changes, retardation, and despair. Multivariate Logistic regression analysis showed that anxiety was an independent risk factor for depression in pPD. Conclusion: Depression is common in prodromal PD and exhibit a multifaceted nature. pPD subjects with depression are vulnerable to comorbid with other non-motor symptoms. Anxiety is an established risk factor for ndPD, which indicates the critical value of early mood management in early disease intervention.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.